Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. BD's operations consist of three business segments: BD Medical, BD Diagnostics and BD Biosciences. On February 9, 2012, the Company acquired a 100% interest in KIESTRA Lab Automation BV. On August 24, 2012, the Company acquired a 100% interest in Sirigen Group Limited. On October 31, 2012, the Company sold its BD Biosciences -Discovery Labware unit. In December 2012, the Company acquired Safety Syringes, Inc.... (Source: SEC reports)
Competitor - 1/8
Which company is more competitive with Becton Dickinson?
FRANKLIN LAKES, N.J., Oct. 3, 2018 /PRNewswire/ --Â BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Tom Polen will add the responsibility of [...]